nejm.org/doi/full/10.10 #MedTwitter #GLP1 #Endocrinology #ObesityMedicine GLP-1 receptor agonists are doing more than glucose control, with effects across appetite, heart, kidney, and metabolism
Worth knowing: none of the peptides we use are FDA-approved for these purposes, and we're upfront about where each one sits on the evidence curve
The key word in the safety data is "no increase in serious cardiovascular events." That said, the absence of evidence is not evidence of absence
A major one is any product labeled for research only. This is a way some sellers skirt the fact that their product isnt FDA-approved, and it basically means the drug or supplement isnt meant for human use or treatment
Adequate protein, fiber-rich eating, consistent movement, quality sleep, stress management, and a healthy gut microbiome all work in your favor no matter which medication you are taking
Certain individuals may not qualify for tirzepatide treatment due to previous medical conditions such as pancreatitis, medullary thyroid cancer, severe gastrointestinal disorders, or allergies to GLP-1 receptor agonists